Week of February 14th 2022 | Vol. 11, Issue 7
Events Hosted or Attended by Bourne Partners
March 21-24, 2022 - New York City, NY
May 17-19, 2022 - Philadelphia, PA
May 24-26, 2022 - New York City, NY
June 13-16, 2022 - San Diego, CA
October 2022 - Charlotte, NC
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
Insight Into Healthcare Related Industries
Representative Current Retained Sell-Side And Partnering Opportunities
Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
A Sampling of Industry Headlines From Last Week
Takeda Ventures has joined Novartis and Merck in backing Koneksa Health, which bills itself as a digital biomarker company. Koneksa's platform stands to benefit from the renewed interest the COVID-19 pandemic brought to remote monitoring of clinical trials.
CooperSurgical has inked an $875 million deal to purchase Cook Medical's reproductive health portfolio, which includes medical devices for fertility, obstetrics, gynecology and in vitro fertilization.
Two U.S. senators introduced bipartisan legislation Monday to extend current Medicare telehealth reimbursement waivers an additional two years following the end of the public health emergency.
Spider-inspired technology isn’t just for comic book characters anymore.  A biomaterial that’s made of silk and takes its construction cues from the strength of spiderwebs has the potential to replace worn-down cartilage around the human knee.

Life-changing treatments might take years to pass necessary regulatory approvals in certain countries, if at all. Tanner enables patient access to innovative medicines through EAPs. Learn more.

The availability of pharmaceuticals can be limited in certain emerging markets around the world. Learn more about how TannerLAC ensures products reach patients in Latin America in this Q&A with Carolina Cortez and Margarita Chala.